Búsqueda | Biblioteca Virtual en Salud

1.

Hepatocyte nuclear factor-1alpha is an essential regulator of bile acid and plasma cholesterol metabolism.

Shih, D Q; Bussen, M; Sehayek, E; Ananthanarayanan, M; Shneider, B L; Suchy, F J; Shefer, S; Bollileni, J S; Gonzalez, F J; Breslow, J L; Stoffel, M.

Nat Genet ; 27(4): 375-82, 2001 Apr.

Artículo en Inglés | MEDLINE | ID: mdl-11279518

2.

Lipoprotein lipase enhances binding of lipoproteins to heparan sulfate on cell surfaces and extracellular matrix.

Eisenberg, S; Sehayek, E; Olivecrona, T; Vlodavsky, I.

J Clin Invest ; 90(5): 2013-21, 1992 Nov.

Artículo en Inglés | MEDLINE | ID: mdl-1430223

3.

Lipolysis exposes unreactive endogenous apolipoprotein E-3 in human and rat plasma very low density lipoprotein.

Sehayek, E; Lewin-Velvert, U; Chajek-Shaul, T; Eisenberg, S.

J Clin Invest ; 88(2): 553-60, 1991 Aug.

Artículo en Inglés | MEDLINE | ID: mdl-1864965

4.

Effects of exogenous apo E-3 and of cholesterol-enriched meals on the cellular metabolism of human chylomicrons and their remnants.

Arnon, R; Sehayek, E; Vogel, T; Eisenberg, S.

Biochim Biophys Acta ; 1085(3): 336-42, 1991 Oct 01.

Artículo en Inglés | MEDLINE | ID: mdl-1911868

5.

Significance of high HbA1 levels in normal glucose tolerance.

Modan, M; Meytes, D; Rozeman, P; Yosef, S B; Sehayek, E; Yosef, N B; Lusky, A; Halkin, H.

Diabetes Care ; 11(5): 422-8, 1988 May.

Artículo en Inglés | MEDLINE | ID: mdl-3391093

6.

Binding to heparan sulfate is a major event during catabolism of lipoprotein lipase by HepG2 and other cell cultures.

Sehayek, E; Olivecrona, T; Bengtsson-Olivecrona, G; Vlodavsky, I; Levkovitz, H; Avner, R; Eisenberg, S.

Atherosclerosis ; 114(1): 1-8, 1995 Apr 07.

Artículo en Inglés | MEDLINE | ID: mdl-7605368

7.

Efficacy and safety of a combination fluvastatin-bezafibrate treatment for familial hypercholesterolemia: comparative analysis with a fluvastatin-cholestyramine combination.

Leitersdorf, E; Muratti, E N; Eliav, O; Meiner, V; Eisenberg, S; Dann, E J; Sehayek, E; Peters, T K; Stein, Y.

Am J Med ; 96(5): 401-7, 1994 May.

Artículo en Inglés | MEDLINE | ID: mdl-8192170

8.

Platelet parameters and aggregation in essential and reactive thrombocytosis.

Sehayek, E; Ben-Yosef, N; Modan, M; Chetrit, A; Meytes, D.

Am J Clin Pathol ; 90(4): 431-6, 1988 Oct.

Artículo en Inglés | MEDLINE | ID: mdl-3177264

9.

Memory deficits and cholinergic impairments in apolipoprotein E-deficient mice.

Gordon, I; Grauer, E; Genis, I; Sehayek, E; Michaelson, D M.

Neurosci Lett ; 199(1): 1-4, 1995 Oct 13.

Artículo en Inglés | MEDLINE | ID: mdl-8584214

10.

Phosphorylation of tau in apolipoprotein E-deficient mice.

Genis, I; Gordon, I; Sehayek, E; Michaelson, D M.

Neurosci Lett ; 199(1): 5-8, 1995 Oct 13.

Artículo en Inglés | MEDLINE | ID: mdl-8584225

11.

Derangement in stress response of apolipoprotein E-deficient mice.

Gordon, I; Ben-Eliyahu, S; Rosenne, E; Sehayek, E; Michaelson, D M.

Neurosci Lett ; 206(2-3): 212-4, 1996 Mar 15.

Artículo en Inglés | MEDLINE | ID: mdl-8710189

12.

[Screening and treatment of hyperlipidemias in Israel].

Sehayek, E; Eisenberg, S.

Harefuah ; 128(9): 529-32, 600, 1995 May 01.

Artículo en Hebreo | MEDLINE | ID: mdl-7797148

13.

[Hypercalcemia following rhabdomyolysis-induced acute renal failure].

Izsak, E; Eisenberg, S; Shechter, P; Sehayek, E.

Harefuah ; 128(3): 147-50, 199, 1995 Feb 01.

Artículo en Hebreo | MEDLINE | ID: mdl-7759004

14.

[Proteases, antiproteases, lung emphysema and other smoking damage].

Sehayek, E; Halkin, H.

Harefuah ; 117(3-4): 98-9, 1989 Aug.

Artículo en Hebreo | MEDLINE | ID: mdl-2680831

15.

[Cardioprotective properties of beta-blockers in patients after myocardial infarction].

Sehayek, E; Avni, Y; Jedwab, M.

Harefuah ; 111(12): 427-30, 1986 Dec 15.

Artículo en Hebreo | MEDLINE | ID: mdl-2881852

16.

[Duodenal diverticulum].

Sehayek, E; Bar-Meir, S.

Harefuah ; 110(5): 258-9, 1986 Mar 02.

Artículo en Hebreo | MEDLINE | ID: mdl-3087844

17.

Mechanisms of inhibition by apolipoprotein C of apolipoprotein E-dependent cellular metabolism of human triglyceride-rich lipoproteins through the low density lipoprotein receptor pathway.

Sehayek, E; Eisenberg, S.

J Biol Chem ; 266(27): 18259-67, 1991 Sep 25.

Artículo en Inglés | MEDLINE | ID: mdl-1917954

18.

Remnant particles and their metabolism.

Eisenberg, S; Sehayek, E.

Baillieres Clin Endocrinol Metab ; 9(4): 739-53, 1995 Oct.

Artículo en Inglés | MEDLINE | ID: mdl-8593123

19.

The role of native apolipoprotein B-containing lipoproteins in atherosclerosis: cellular mechanisms.

Sehayek, E; Eisenberg, S.

Curr Opin Lipidol ; 5(5): 350-3, 1994 Oct.

Artículo en Inglés | MEDLINE | ID: mdl-7858909

20.

Abnormal composition of hypertriglyceridemic very low density lipoprotein determines abnormal cell metabolism.

Sehayek, E; Eisenberg, S.

Arteriosclerosis ; 10(6): 1088-96, 1990.

Artículo en Inglés | MEDLINE | ID: mdl-2244857

Biblioteca Virtual en Salud

Hipertensión

Su selección (0)

Formato de exportación:

Exportar:

Hepatocyte nuclear factor-1alpha is an essential regulator of bile acid and plasma cholesterol metabolism.

Lipoprotein lipase enhances binding of lipoproteins to heparan sulfate on cell surfaces and extracellular matrix.

Lipolysis exposes unreactive endogenous apolipoprotein E-3 in human and rat plasma very low density lipoprotein.

Effects of exogenous apo E-3 and of cholesterol-enriched meals on the cellular metabolism of human chylomicrons and their remnants.

Significance of high HbA1 levels in normal glucose tolerance.

Binding to heparan sulfate is a major event during catabolism of lipoprotein lipase by HepG2 and other cell cultures.

Efficacy and safety of a combination fluvastatin-bezafibrate treatment for familial hypercholesterolemia: comparative analysis with a fluvastatin-cholestyramine combination.

Platelet parameters and aggregation in essential and reactive thrombocytosis.

Memory deficits and cholinergic impairments in apolipoprotein E-deficient mice.

Phosphorylation of tau in apolipoprotein E-deficient mice.

Derangement in stress response of apolipoprotein E-deficient mice.

[Screening and treatment of hyperlipidemias in Israel].

[Hypercalcemia following rhabdomyolysis-induced acute renal failure].

[Proteases, antiproteases, lung emphysema and other smoking damage].

[Cardioprotective properties of beta-blockers in patients after myocardial infarction].

[Duodenal diverticulum].

Mechanisms of inhibition by apolipoprotein C of apolipoprotein E-dependent cellular metabolism of human triglyceride-rich lipoproteins through the low density lipoprotein receptor pathway.

Remnant particles and their metabolism.

The role of native apolipoprotein B-containing lipoproteins in atherosclerosis: cellular mechanisms.

Abnormal composition of hypertriglyceridemic very low density lipoprotein determines abnormal cell metabolism.